Deciphering the Intricate Molecular Bases of Atrial Fibrillation
Funding
Conflicts of Interest
References
- Wijesurendra, R.S.; Casadei, B. Mechanisms of atrial fibrillation. Heart 2019, 105, 1860–1867. [Google Scholar] [CrossRef] [PubMed]
- Kornej, J.; Börschel, C.S.; Benjamin, E.J.; Schnabel, R.B. Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights. Circ. Res. 2020, 127, 4–20. [Google Scholar] [CrossRef]
- Brundel, B.J.J.M.; Ai, X.; Hills, M.T.; Kuipers, M.F.; Lip, G.Y.H.; de Groot, N.M.S. Atrial fibrillation. Nat. Rev. Dis. Primers 2022, 8, 21. [Google Scholar] [CrossRef] [PubMed]
- Kowalewski, C. Mapping atrial fibrillation: An overview of potential mechanisms underlying atrial fibrillation. Herz 2021, 46, 305–311. [Google Scholar] [CrossRef] [PubMed]
- Elbatran, A.I.; Anderson, R.H.; Mori, S.; Saba, M.M. The rationale for isolation of the left atrial pulmonary venous component to control atrial fibrillation: A review article. Heart Rhythm 2019, 16, 1392–1398. [Google Scholar] [CrossRef]
- Jost, N.; Christ, T.; Magyar, J. New Strategies for the Treatment of Atrial Fibrillation. Pharmaceuticals 2021, 14, 926. [Google Scholar] [CrossRef]
- Lozano-Velasco, E.; Franco, D.; Aranega, A.; Daimi, H. Genetics and Epigenetics of Atrial Fibrillation. Int. J. Mol. Sci. 2020, 21, 5717. [Google Scholar] [CrossRef]
- Feghaly, J.; Zakka, P.; London, B.; MacRae, C.A.; Refaat, M.M. Genetics of Atrial Fibrillation. J. Am. Heart Assoc. 2018, 7, e009884. [Google Scholar] [CrossRef]
- Lozano-Velasco, E.; Garcia-Padilla, C.; Aránega, A.E.; Franco, D. Genetics of Atrial Fibrilation: In Search of Novel Therapeutic Targets. Cardiovasc. Hematol. Disord. Drug Targets 2019, 19, 183–194. [Google Scholar] [CrossRef]
- Gudbjartsson, D.F.; Arnar, D.O.; Helgadottir, A.; Gretarsdottir, S.; Holm, H.; Sigurdsson, A.; Jonasdottir, A.; Baker, A.; Thorleifsson, G.; Kristjansson, K.; et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007, 448, 353–357. [Google Scholar] [CrossRef]
- Franco, D.; Christoffels, V.M.; Campione, M. Homeobox transcription factor Pitx2: The rise of an asymmetry gene in cardiogenesis and arrhythmogenesis. Trends Cardiovasc. Med. 2014, 24, 23–31. [Google Scholar] [CrossRef] [PubMed]
- Campione, M.; Ros, M.A.; Icardo, J.M.; Piedra, E.; Christoffels, V.M.; Schweickert, A.; Blum, M.; Franco, D.; Moorman, A.F. Pitx2 expression defines a left cardiac lineage of cells: Evidence for atrial and ventricular molecular isomerism in the iv/iv mice. Dev. Biol. 2001, 231, 252–264. [Google Scholar] [CrossRef] [PubMed]
- Franco, D.; Campione, M.; Kelly, R.; Zammit, P.S.; Buckingham, M.; Lamers, W.H.; Moorman, A.F. Multiple transcriptional domains, with distinct left and right components, in the atrial chambers of the developing heart. Circ. Res. 2000, 87, 984–991. [Google Scholar] [CrossRef] [PubMed]
- Wang, J.; Klysik, E.; Sood, S.; Johnson, R.L.; Wehrens, X.H.; Martin, J.F. Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification. Proc. Natl. Acad. Sci. USA 2010, 107, 9753–9758. [Google Scholar] [CrossRef]
- Chinchilla, A.; Daimi, H.; Lozano-Velasco, E.; Dominguez, J.N.; Caballero, R.; Delpón, E.; Tamargo, J.; Cinca, J.; Hove-Madsen, L.; Aranega, A.E.; et al. PITX2 insufficiency leads to atrial electrical and structural remodeling linked to arrhythmogenesis. Circ. Cardiovasc. Genet. 2011, 4, 269–279. [Google Scholar] [CrossRef]
- Kirchhof, P.; Kahr, P.C.; Kaese, S.; Piccini, I.; Vokshi, I.; Scheld, H.H.; Rotering, H.; Fortmueller, L.; Laakmann, S.; Verheule, S.; et al. PITX2c is expressed in the adult left atrium, and reducing Pitx2c expression promotes atrial fibrillation inducibility and complex changes in gene expression. Circ. Cardiovasc. Genet. 2011, 4, 123–133. [Google Scholar] [CrossRef]
- Lozano-Velasco, E.; Hernández-Torres, F.; Daimi, H.; Serra, S.A.; Herraiz, A.; Hove-Madsen, L.; Aránega, A.; Franco, D. Pitx2 impairs calcium handling in a dose-dependent manner by modulating Wnt signalling. Cardiovasc. Res. 2016, 109, 55–66. [Google Scholar] [CrossRef]
- Lozano-Velasco, E.; Wangensteen, R.; Quesada, A.; Garcia-Padilla, C.; Osorio, J.A.; Ruiz-Torres, M.D.; Aranega, A.; Franco, D. Hyperthyroidism, but not hypertension, impairs PITX2 expression leading to Wnt-microRNA-ion channel remodeling. PLoS ONE 2017, 12, e0188473. [Google Scholar] [CrossRef]
- Zhang, M.; Hill, M.C.; Kadow, Z.A.; Suh, J.H.; Tucker, N.R.; Hall, A.W.; Tran, T.T.; Swinton, P.S.; Leach, J.P.; Margulies, K.B.; et al. Long-range Pitx2c enhancer-promoter interactions prevent predisposition to atrial fibrillation. Proc. Natl. Acad. Sci. USA 2019, 116, 22692–22698. [Google Scholar] [CrossRef]
- Aguirre, L.A.; Alonso, M.E.; Badía-Careaga, C.; Rollán, I.; Arias, C.; Fernández-Miñán, A.; López-Jiménez, E.; Aránega, A.; Gómez-Skarmeta, J.L.; Franco, D.; et al. Long- range regulatory interactions at the 4q25 atrial fibrillation risk locus involve PITX2c and ENPEP. BMC Biol. 2015, 13, 26. [Google Scholar] [CrossRef]
- Ye, J.; Tucker, N.R.; Weng, L.C.; Clauss, S.; Lubitz, S.A.; Ellinor, P.T. A Functional Variant Associated with Atrial Fibrillation Regulates PITX2c Expression through TFAP2a. Am. J. Hum. Genet. 2016, 99, 1281–1291. [Google Scholar] [CrossRef] [PubMed]
- van Ouwerkerk, A.F.; Bosada, F.M.; van Duijvenboden, K.; Hill, M.C.; Montefiori, L.E.; Scholman, K.T.; Liu, J.; de Vries, A.A.F.; Boukens, B.J.; Ellinor, P.T.; et al. Identification of atrial fibrillation associated genes and functional non-coding variants. Nat. Commun. 2019, 10, 4755. [Google Scholar] [CrossRef] [PubMed]
- Roselli, C.; Chaffin, M.D.; Weng, L.C.; Aeschbacher, S.; Ahlberg, G.; Albert, C.M.; Almgren, P.; Alonso, A.; Anderson, C.D.; Aragam, K.G.; et al. Multi-ethnic genome-wide association study for atrial fibrillation. Nat. Genet. 2018, 50, 1225–1233. [Google Scholar] [CrossRef] [PubMed]
- Beneke, K.; Molina, C.E. Molecular Basis of Atrial Fibrillation Initiation and Maintenance. Hearts 2021, 2, 170–187. [Google Scholar] [CrossRef]
- Herraiz-Martínez, A.; Tarifa, C.; Lozano-Velasco, E.; Jiménez-Sábado, V.; Casabella, S.; Hernández-Torres, F.; Daimi, H.; Vázquez Ruiz de Castroviejo, E.; Delpón, E.; Caballero, R.; et al. Novel PITX2 Homeodomain-Contained Mutations from ATRIAL Fibrillation Patients Deteriorate Calcium Homeostasis. Hearts 2021, 2, 251–269. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Franco, D. Deciphering the Intricate Molecular Bases of Atrial Fibrillation. Hearts 2023, 4, 78-80. https://doi.org/10.3390/hearts4040010
Franco D. Deciphering the Intricate Molecular Bases of Atrial Fibrillation. Hearts. 2023; 4(4):78-80. https://doi.org/10.3390/hearts4040010
Chicago/Turabian StyleFranco, Diego. 2023. "Deciphering the Intricate Molecular Bases of Atrial Fibrillation" Hearts 4, no. 4: 78-80. https://doi.org/10.3390/hearts4040010